As HCE the incumbent is expected to be a vital interface between the Company and the medical profession by briefing them on the scientific features and patient care benefits in respect of companys products, consistently achieve budgeted sales of the products in the assigned territory through planned coverage and systematic implementation of promotional strategies and customer service initiatives and reporting thereof.
Sciences or Pharmacy Graduates B.Sc./M.Sc./B. Pharm./M.Pharm. with 0 to 2 years Experiences in parenteral manufacturing QMS / IPQA. Candidate worked in compliances / remediation / and having experiences of managing quality system document CCN / CAPA / investigation etc.
Assist in the development of regulatory strategies and implementation in an effort to manage complex issues that may have a significant impact on the Company’s internal and external product portfolio and product approval process.
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.
Post : Research Associate / Scientist
Department : Regulatory Affairs Division : APL RC I Location : Bachupally
After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.
A pharmaceutical generics business company. HPRA Approved (April 2021) facility for veterinary generic medicines. Parent entity based in Ireland. Indian corporate office located at Gurgaon and R&D Center is at Greater Noida. Manufacturing facility based at SEZ Pithampur, Indore.
Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka, India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.